Related references
Note: Only part of the references are listed.The prognostic value of C-reactive protein and albumin in patients undergoing resection of colorectal liver metastases. A retrospective cohort study
Petter Fruhling et al.
HPB (2021)
Predicting Survival in Colorectal Liver Metastasis: Time for New Approaches
Georgios Antonios Margonis et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases
Hauke Lang et al.
ANNALS OF SURGERY (2019)
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases
Kristoffer W. Brudvik et al.
ANNALS OF SURGERY (2019)
Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients
Xin Lu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
The Tumor Burden Score: A New Metro-ticket Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors
Kazunari Sasaki et al.
ANNALS OF SURGERY (2018)
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases
G. A. Margonis et al.
BRITISH JOURNAL OF SURGERY (2018)
Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases
Kerstin Wimmer et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
Julian Walter Holch et al.
EUROPEAN JOURNAL OF CANCER (2017)
The prognostic utility of the Tumor Burden Score based on preoperative radiographic features of colorectal liver metastases
Kazunari Sasaki et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker
Anne Helene Kostner et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
N. Ayez et al.
EJSO (2015)
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data
Didier Meulendijks et al.
LANCET ONCOLOGY (2015)
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review
Shiva Shrotriya et al.
PLOS ONE (2015)
External validation of a Cox prognostic model: principles and methods
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
Prognosis research strategy (PROGRESS) 4: Stratified medicine research
Aroon D. Hingorani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
Harry Hemingway et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
Richard D. Riley et al.
PLOS MEDICINE (2013)
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
Ewout W. Steyerberg et al.
PLOS MEDICINE (2013)
Non-Size-Based Response Criteria to Preoperative Chemotherapy in Patients With Colorectal Liver Metastases: The Morphologic Response Criteria
Junichi Shindoh et al.
CURRENT COLORECTAL CANCER REPORTS (2013)
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
R. P. Jones et al.
BRITISH JOURNAL OF SURGERY (2012)
The Prevention and Treatment of Missing Data in Clinical Trials
Roderick J. Little et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
Ryan B. Corcoran et al.
CANCER DISCOVERY (2012)
Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy?
Ninos Ayez et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Impact of BRAF Mutation and Microsatellite Instability on the Pattern of Metastatic Spread and Prognosis in Metastatic Colorectal Cancer
Ben Tran et al.
CANCER (2011)
Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis
Gianluca Masi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Reporting performance of prognostic models in cancer: a review
Susan Mallett et al.
BMC MEDICINE (2010)
Missing Data Analysis Using Multiple Imputation Getting to the Heart of the Matter
Yulei He
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Assessing the Performance of Prediction Models A Framework for Traditional and Novel Measures
Ewout W. Steyerberg et al.
EPIDEMIOLOGY (2010)
Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution
Michael G. House et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?
Dhanwant Gomez et al.
HPB (2010)
Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases
Ralf Konopke et al.
LIVER INTERNATIONAL (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Prognosis and prognostic research: application and impact of prognostic models in clinical practice
Karel G. M. Moons et al.
BRITISH MEDICAL JOURNAL (2009)
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer
Michael W. Kattan et al.
ANNALS OF SURGERY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2006)
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2005)
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2004)
A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection
I Nagashima et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2004)
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2003)
Share Paper
